Bennett Jean 4

What Happened

• Bennett Jean, a director of Opus Genetics, was granted 24,367 restricted stock units (RSUs) on 2026-04-20. The Form 4 reports the award at $0.00 per share (total reported value $0) because these are equity awards, not a cash purchase.
• This is an award (not a sale or open-market purchase) and does not represent immediate proceeds or a share sale.

Key Details

• Transaction date: April 20, 2026; Form 4 filed April 22, 2026 (filed within the typical 2-business-day window).
• Grant: 24,367 RSUs reported at $0.00 per unit.
• Shares owned after transaction: not specified in the filing.
• Vesting: RSUs vest upon the earlier of the one-year anniversary of the grant or the day prior to the issuer’s next annual meeting, contingent on continued service (see footnote).
• Transaction code: A = Award/Grant.

Context

• RSUs are a deferred equity award that convert into shares only if/when they vest; they are commonly used for director compensation and do not necessarily indicate a buy/sell signal.
• Because this is an award, it increases potential future dilution only if and when the units vest and convert to shares; it does not reflect an immediate market transaction.